FPC Investment Advisory’s Merck MRK Stock Holding History

FPC Investment Advisory’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-94	Closed	-$9.29K	–	173
2024 Q4	$9.29K	Buy	+94	New	+$9.69K	0.01%	174

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPC Investment Advisory's MRK Position: Q1 2025 in Review

FPC Investment Advisory sold out of Merck (MRK) in Q1 2025, closing a stake of 94 shares — an estimated $9.29K sold.

FPC Investment Advisory first reported a position in MRK in Q4 2024 and held it in 1 quarter. The position peaked at $9.29K in Q4 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

FPC Investment Advisory reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
FPC Investment Advisory sold 94 Merck shares in Q1 2025, an estimated $9.29K.
FPC Investment Advisory first reported a position in Merck in Q4 2024 and held it in 1 quarter.
FPC Investment Advisory's Merck position peaked at $9.29K in Q4 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on FPC Investment Advisory's 13F filing for Q1 2025, filed 6 May 2025.